Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.36 |
| ▸ | HPGD | P15428 | 4/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 10/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29511993 | 1.00 | CYP1A2 (0.41) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL29516969 | 1.00 | CYP1A2 (0.41) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL3693920 | 1.00 | CYP1A2 (0.41) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL18929824 | 0.94 | CYP1A2 (0.42) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL21176145 | 0.90 | CYP1A2 (0.40) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL12203352 | 0.89 | ERBB2 (0.33) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL27545245 | 0.88 | CYP1A2 (0.35) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL18473208 | 0.88 | CYP1A2 (0.36) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL23098389 | 0.87 | CYP1A2 (0.40) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL1520771 | 0.85 | ALDH1A1 (0.42) | CYP1A2ERBB2FYNMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4592297-A1 | AN ORGANIC BORON COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE ORGANIC BORON COMPOUND, A USE OF THE DIODE, AND A CONSUMER PRODUCT | Noctiluca S.A. (PL) | 2025-07-30 | — | — | EP | claimed |
| US-12622132-B2 | Light-emitting device, light-emitting apparatus, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-12585189-B2 | Method for manufacturing cured film and use of the same | MERCK PATENT GMBH (DE) | 2026-03-24 | — | — | US | disclosed |
| US-12545650-B2 | Bisanthracene derivatives having solubilizing substituent, and organic electroluminescence device using same | LG CHEM, LTD. (KR) | 2026-02-10 | — | — | US | disclosed |
| EP-4592297-A1 | AN ORGANIC BORON COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE ORGANIC BORON COMPOUND, A USE OF THE DIODE, AND A CONSUMER PRODUCT | Noctiluca S.A. (PL) | 2025-07-30 | — | — | EP | disclosed |
| US-20250102917-A1 | METHOD FOR MANUFACTURING CURED FILM AND USE OF THE SAME | MERCK PATENT GMBH (DE) | 2025-03-27 | — | — | US | disclosed |
| US-12242195-B2 | Method for manufacturing cured film and use of the same | MERCK PATENT GMBH (DE) | 2025-03-04 | — | — | US | disclosed |
| EP-3327815-B1 | LIGHT-EMITTING DEVICE | IMEC VZW (BE) | 2024-11-06 | — | — | EP | disclosed |
| US-12041844-B2 | Organic light emitting device | NOVALED GMBH (DE) | 2024-07-16 | — | — | US | disclosed |
| CN-118284274-A | Charge-transporting varnish | 日产化学株式会社 | 2024-07-02 | — | — | CN | disclosed |
| EP-2786435-A1 | DISPLAY | Novaled GmbH (DE) | 2014-10-08 | — | — | EP | disclosed |
| US-8778512-B2 | Chemical compound for organic electronic device and organic electronic device | NOVALED AG (DE) | 2014-07-15 | — | — | US | disclosed |
| EP-2452946-B1 | Pyridylphosphinoxides for organic electronic device and organic electronic device | NOVALED AG (DE) | 2014-05-07 | — | — | EP | disclosed |
| EP-2463927-B1 | Material for organic electronic device and organic electronic device | NOVALED AG (DE) | 2013-08-21 | — | — | EP | disclosed |
| WO-2013079217-A1 | DISPLAY | NOVALED AG (DE) | 2013-06-06 | — | — | WO | disclosed |
| US-8421346-B2 | Composite material, light-emitting element, light-emitting device, lighting device, electronic device, and fluorene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-04-16 | — | — | US | disclosed |
| US-20120194062-A1 | Composite Material, Light-Emitting Element, Light-Emitting Device, Lighting Device, Electronic Device, and Fluorene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-08-02 | — | — | US | disclosed |
| EP-2463927-A1 | Material for organic electronic device and organic electronic device | Novaled AG (DE) | 2012-06-13 | — | — | EP | disclosed |
| US-20120119191-A1 | Chemical Compound for Organic Electronic Device and Organic Electronic Device | NOVALED AG (DE) | 2012-05-17 | — | — | US | disclosed |
| EP-2452946-A1 | Pyridylphosphinoxides for organic electronic device and organic electronic device | Novaled AG (DE) | 2012-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622132-B2 | Light-emitting device, light-emitting apparatus, electronic device, and lighting device | CYBA, NFE2L2, AOX1 | CYP1A2 280/4885ERBB2 1564/4885FYN 3276/4885 |
| US-12585189-B2 | Method for manufacturing cured film and use of the same | C9, RAD51, VCL | CYP1A2 2078/4885ERBB2 4041/4885FYN 4778/4885 |
| US-12545650-B2 | Bisanthracene derivatives having solubilizing substituent, and organic electroluminescence device using same | NCOR2, NCOR1, ESR2 | CYP1A2 585/4885ERBB2 1151/4885FYN 2270/4885 |
| US-20120119191-A1 | Chemical Compound for Organic Electronic Device and Organic Electronic Device | SLCO4C1, OR10J3, EPCAM | CYP1A2 44/4885ERBB2 1494/4885FYN 2894/4885 |
| US-20120194062-A1 | Composite Material, Light-Emitting Element, Light-Emitting Device, Lighting Device, Electronic Device, and Fluorene Derivative | ELOVL1, TRPA1, FLI1 | CYP1A2 1921/4885ERBB2 4739/4885FYN 3498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.